All max achieved past history displayed. Forward in the future to 70$ today.
Could be a 10 banger.
Lower supply/increasing demand/low oil prices should force NG to $3.50 in the coming month before year end.
Phase 3 product with huge market potential to treat wet AMD. Company has about $2 cash and currently trading at $4.
Real biotech with tangible results in the field of oncology.
Price target $5-6
Hunting fish pattern formation. Short term target price 930 in December.
Bullish cycle continuation for Impala/Platinum. Target 15000.
Predicting an acceleration in PPS.
